Post-approval studies (Phase 4)Study completedNCT06041646
What this trial is testing
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Who this might be right for
Bipolar DisorderSchizophreniaAgitation,Psychomotor+2 more
BioXcel Therapeutics Inc 29